TWO · Healthcare

Orient Pharma Co. Ltd. (4166)

Drug Manufacturers - Specialty & Generic

Orient Pharma Co. Ltd. (4166) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 4166

P/E ratio
18.00

Orient Pharma Co. Ltd. (4166) — FAQ

What is 4166's P/E ratio?

The price-to-earnings (P/E) ratio for Orient Pharma Co. Ltd. (4166) is 18.00 (data as of 2026-05-23).

Does Orient Pharma Co. Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Orient Pharma Co. Ltd. (4166). Check the MyAverix Finance app for the latest dividend data.

What sector is Orient Pharma Co. Ltd. in?

Orient Pharma Co. Ltd. (4166) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 4166 listed on?

4166 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play